LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy

Autophagy

Volumn 8, Issue 11, 2012, Pages 1643-1656

  Saha, Tapas ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Autophagy; CMA; Doxorubicin; PCC; Tissues; Tumor; TUNEL

Indexed keywords

CARBONYL DERIVATIVE; DOXORUBICIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2A; PROTEIN KINASE B; PYRUVATE KINASE; PYRUVATE KINASE M2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL SURVIVAL; CHAPERONE-MEDIATED AUTOPHAGY; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

EID: 84869428389     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.21654     Document Type: Article

References (53)

1. Majeski AE, Dice JF. Mechanisms of chaperonemediated autophagy. Int J Biochem Cell Biol 2004; 36:2435-44; PMID:15325583; http://dx.doi.org/10.1016/j. biocel.2004.02.013
2. Massey A, Kiffin R, Cuervo AM. Pathophysiology of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004; 36:2420-34; PMID:15325582; http://dx.doi.org/10.1016/j.biocel.2004.04.010
3. Zhou D, Li P, Lin Y, Lott JM, Hislop AD, Canaday DH, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005; 22:571-81; PMID:15894275; http://dx.doi.org/10.1016/j.immuni.2005.03.009
4. Di Blasi C, Jarre L, Blasevich F, Dassi P, Mora M. Danon disease: a novel LAMP2 mutation affecting the pre-mRNA splicing and causing aberrant transcripts and partial protein expression. Neuromuscul Disord 2008; 18:962-6; PMID:18990578; http://dx.doi.org/10.1016/j.nmd.2008.09.008
5. Massey AC, Zhang C, Cuervo AM. Chaperonemediated autophagy in aging and disease. Curr Top Dev Biol 2006; 73:205-35; PMID:16782460; http://dx.doi.org/10. 1016/S0070-2153(05)73007-6
6. Nixon RA. Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 2006; 29:528- 35; PMID:16859759; http://dx.doi.org/10. 1016/j.tins.2006.07.003
7. Saftig P, Tanaka Y, Lüllmann-Rauch R, von Figura K. Disease model: LAMP-2 enlightens Danon disease. Trends Mol Med 2001; 7:37-9; PMID:11427988; http://dx.doi.org/10.1016/S1471-4914(00)01868-2
8. Venugopal B, Mesires NT, Kennedy JC, Curcio-Morelli C, Laplante JM, Dice JF, et al. Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol 2009; 219:344-53; PMID:19117012; http://dx.doi.org/10.1002/jcp. 21676
9. Eskelinen EL, Cuervo AM, Taylor MR, Nishino I, Blum JS, Dice JF, et al. Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2. Traffic 2005; 6:1058-61; PMID:16190986; http://dx.doi.org/10.1111/j.1600-0854. 2005.00337.x
10. Gough NR, Fambrough DM. Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue. J Cell Biol 1997; 137:1161-9; PMID:9166415; http://dx.doi.org/10.1083/jcb.137.5.1161
11. Cook NR, Row PE, Davidson HW. Lysosome associated membrane protein 1 (Lamp1) traffics directly from the TGN to early endosomes. Traffic 2004; 5:685-99; PMID:15296493; http://dx.doi.org/10.1111/j.1600-0854.2004.00212.x
12. Furuta K, Ikeda M, Nakayama Y, Nakamura K, Tanaka M, Hamasaki N, et al. Expression of lysosomeassociated membrane proteins in human colorectal neoplasms and inflammatory diseases. Am J Pathol 2001; 159:449-55; PMID:11485903; http://dx.doi.org/10.1016/S0002-9440(10)61716-6
13. Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 2006; 27:495-502; PMID:16973206; http://dx.doi.org/ 10.1016/j.mam.2006.08.005
14. Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, et al. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 2004; 15:3132-45; PMID:15121881; http://dx.doi.org/10.1091/mbc.E04-02-0103
15. Saftig P, Beertsen W, Eskelinen EL. LAMP-2: a control step for phagosome and autophagosome maturation. Autophagy 2008; 4:510-2; PMID:18376150
16. Cuervo AM, Dice JF. Regulation of lamp2a levels in the lysosomal membrane. Traffic 2000; 1:570-83; PMID:11208145; http://dx.doi.org/10.1034/j. 1600-0854.2000.010707.x
17. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15:5308-16; PMID:19706824; http://dx.doi.org/10. 1158/1078-0432.CCR-07-5023
18. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21:1621-35; PMID:17606641; http://dx.doi.org/10. 1101/gad.1565707
19. Kiffin R, Christian C, Knecht E, Cuervo AM. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004; 15:4829-40; PMID:15331765; http://dx.doi.org/10.1091/mbc.E04-06-0477
20. Welsch T, Younsi A, Disanza A, Rodriguez JA, Cuervo AM, Scita G, et al. Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells. Exp Cell Res 2010; 316:1914-24; PMID:20184880; http://dx.doi.org/10.1016/j.yexcr.2010.02.020
21. Kon M, Kiffin R, Koga H, Chapochnick J, Macian F, Varticovski L, et al. Chaperone-mediated autophagy is required for tumor growth. Sci Transl Med 2011; 3:ra117; PMID:22089453; http://dx.doi.org/10.1126/scitranslmed.3003182
22. Sooparb S, Price SR, Shaoguang J, Franch HA. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004; 65:2135-44; PMID:15149326; http://dx.doi.org/10.1111/j.1523- 1755.2004.00639.x
23. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998; 8:397-403; PMID:9789328; http://dx.doi.org/ 10.1016/S0962-8924(98)01346-4
24. Shacka JJ, Klocke BJ, Roth KA. Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolideinduced neuroprotection. Autophagy 2006; 2:228-30; PMID:16874105
25. Koga H, Martinez-Vicente M, Macian F, Verkhusha VV, Cuervo AM. A photoconvertible fluorescent reporter to track chaperone-mediated autophagy. Nat Commun 2011; 2:386; PMID:21750540; http://dx.doi.org/10.1038/ncomms1393
26. Stroikin Y, Dalen H, Lööf S, Terman A. Inhibition of autophagy with 3-methyladenine results in impaired turnover of lysosomes and accumulation of lipofuscin- like material. Eur J Cell Biol 2004; 83:583-90; PMID:15679103; http://dx.doi.org/10.1078/0171-9335-00433
27. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 2008; 172:250-4; PMID:18571732; http://dx.doi.org/10.1016/j.jneumeth.2008.05.003
28. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, et al. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probes 2005; 19:101- 9; PMID:15680211; http://dx.doi.org/10.1016/j.mcp.2004.10.001
29. Saha T, Rih JK, Rosen EM. BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett 2009; 583:1535-43; PMID:19364506; http://dx.doi.org/10.1016/j.febslet.2009.04.005
30. Saha T, Rih JK, Roy R, Ballal R, Rosen EM. Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem 2010; 285:19092- 105; PMID:20185827; http://dx.doi.org/10.1074/jbc.M110.104430
31. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004; 30:193- 204; PMID:15023437; http://dx.doi.org/10.1016/j.ctrv. 2003.07.007
32. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-10; PMID:12001991; http://dx.doi.org/10.1038/nrc780
33. Franch HA, Wang X, Sooparb S, Brown NS, Du J. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J Am Soc Nephrol 2002; 13:903-9; PMID:11912249
34. Shen W, Brown NS, Finn PF, Dice JF, Franch HA. Akt and Mammalian target of rapamycin regulate separate systems of proteolysis in renal tubular cells. J Am Soc Nephrol 2006; 17:2414-23; PMID:16885413; http://dx.doi.org/10.1681/ASN. 2005111157
35. Tanaka K, Kawakami T, Tateishi K, Yashiroda H, Chiba T. Control of IkappaBalpha proteolysis by the ubiquitin- proteasome pathway. Biochimie 2001; 83:351-6; PMID:11295496; http://dx.doi.org/10.1016/S0300-9084(01)01237-8
36. Havelka AM, Berndtsson M, Olofsson MH, Shoshan MC, Linder S. Mechanisms of action of DNAdamaging anticancer drugs in treatment of carcinomas: is acute apoptoss an "off-target" effect? Mini Rev Med Chem 2007; 7:1035-9; PMID:17979806; http://dx.doi.org/10.2174/138955707782110196
37. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, et al. The role of autophagy during the early neonatal starvation period. Nature 2004; 432:1032-6; PMID:15525940; http://dx.doi.org/10.1038/nature03029
38. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237-48; PMID:15680329; http://dx.doi.org/10.1016/j.cell.2004.11. 046
39. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51- 64; PMID:16843265; http://dx.doi.org/ 10.1016/j.ccr.2006.06.001
40. Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 2005; 6:505-10; PMID:15928714; http://dx.doi.org/10.1038/nrm1666
41. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008; 19:2179-92; PMID:18337468; http://dx.doi.org/10.1091/mbc.E07-11-1155
42. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434:917-21; PMID:15829967; http://dx.doi.org/10.1038/nature03445
43. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326- 36; PMID:17235397; http://dx.doi.org/10.1172/JCI28833
44. Liu W, Bagaitkar J, Watabe K. Roles of AKT signal in breast cancer. Front Biosci 2007; 12:4011-9; PMID:17485354; http://dx.doi.org/10.2741/2367
45. Shcherbakov AM, Gershtein ES, Anurova OA, Kushlinskii NE. Activated proteinkinase B in breast cancer. Bull Exp Biol Med 2005; 139:608-10; PMID:16224561; http://dx.doi.org/10.1007/s10517-005-0357-4
46. Tokunaga E, Kimura Y, Mashino K, Oki E, Kataoka A, Ohno S, et al. Activation of PI3K/Akt signaling and hormone resistance in breast cancer. Breast Cancer 2006; 13:137-44; PMID:16755107; http://dx.doi.org/10.2325/jbcs.13.137
47. Pham FH, Sugden PH, Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res 2000; 86:1252-8; PMID:10864916; http://dx.doi.org/10.1161/01.RES.86.12.1252
48. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem 1999; 274:22699-704; PMID:10428852; http://dx.doi.org/10.1074/jbc.274.32.22699
49. van den Berg MC, Burgering BM. Integrating Opposing Signals Toward Forkhead Box O. Antioxid Redox Signal 2011; 14:607-21; PMID:20624032; http://dx.doi.org/10.1089/ars.2010.3415
50. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 2008; 14:458-70; PMID:19061837; http://dx.doi.org/10.1016/j.ccr.2008.11.003
51. Fan S, Meng Q, Saha T, Sarkar FH, Rosen EM. Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner. Cancer Res 2009; 69:6083-91; PMID:19622773; http://dx.doi.org/10.1158/0008-5472.CAN-08-3309
52. Saha T, Ghosh S, Vassilev A, DePamphilis ML. Ubiquitylation, phosphorylation and Orc2 modulate the subcellular location of Orc1 and prevent it from inducing apoptosis. J Cell Sci 2006; 119:1371- 82; PMID:16537645; http://dx.doi.org/10.1242/jcs.02851
53. Saha T, Smulson M, Rosen EM. BRCA1 regulation of base excision repair pathway. Cell Cycle 2010; 9:2471- 2; PMID:20581465